Skip to search formSkip to main contentSkip to account menu

0.05 ML aflibercept 40 MG/ML Injection

Known as: AFLIBERCEPT 2MG/0.05ML INJ,OPH, aflibercept 2 MG per 0.05 ML Intravitreal Injection, AFLIBERCEPT 2MG/0.05ML INJ,OPH [VA Product] 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

0.05 ML aflibercept 40 MG/ML Injection [Eylea]
Injectionaflibercept

Broader (1)

OPHTHALMICS,OTHER

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Non-neovascular subretinal fluid secondary to choroidal osteoma controlled with intravitreal aflibercept – A case report
The aim of the study was to describe a case of subretinal fluid without neovascularization due to choroidal osteoma that was… 
2019
2019
İNTRAVİTREAL ENJEKSİYON HASTALARINDA BLEFAROSTA TİPİNİN GÖZİÇİ BASINCINA ETKİSİ
OZET Amac: Intravitreal enjeksiyon yapilan hastalarda kullanilan blefarosta (goz spekulumu) tipinin goz ici basincina etkisinin… 
2016
2016
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report
Background: We present an interesting case of bilateral retinitis pigmentosa (RP)-associated cystoid macular oedema that… 
2016
2016
Das klinische Ergebnis eines Therapiewechsels von Ranibizumab und/oder Bevacizumab zu Aflibercept bei neovaskulärer altersabhängiger Makuladegeneration (AMD)
Zusammenfassung Hintergrund: Bei der Studie handelt es sich um eine retrospektive Auswertung des klinischen Effekts eines… 
2016
2016
Intravitreal aflibercept for rubeosis iridis secondary to proliferative diabetic retinopathy.
The purpose of this article is to report a case with rubeosis iridis treated by intravitreal aflibercept. A 61-year-old man had… 
2015
2015
Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks
In this study, we reported the clinical results of switching from ranibizumab to aflibercept for the treatment of an insufficient… 
2015
2015
Intravitreal Aflibercept as Rescue Therapy for Post-Radiation Cystoid Macular Edema Resistant to Intravitreal Bevacizumab: Outcomes at 1 Year
Background/Aims: To investigate the efficacy of intravitreal aflibercept as rescue therapy for post-radiation cystoid macular… 
2015
2015
Visual and Anatomic Outcomes from VISTA and VIVID Studies of Intravitreal Aflibercept Injection (IAI) in Patients with Diabetic Macular Edema (DME): Effect of Baseline Hemoglobin A1c (HbA1c…
2015
2015
Intravitreal Aflibercept (IVT-AFL) for Diabetic Macular Edema (DME): 3 Year Data from VIVID-DME and VISTA-DME
Purpose To evaluate long-term outcomes with IVT-AFL injection in the treatment of DME. Methods 406 patients (VIVID-DME) and… 
2014
2014
Intravitreal aflibercept for macular oedema due to branch retinal vein occlusion
Purpose To evaluate the efficacy and safety of intravitreal aflibercept (IVT‐AFL) injection compared with macular grid laser… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)